NASDAQ:MEDS Wellgistics Health Q2 2025 Earnings Report $3.81 +0.70 (+22.51%) As of 04:00 PM Eastern ProfileEarnings HistoryForecast Wellgistics Health EPS ResultsActual EPS-$5.50Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AWellgistics Health Revenue ResultsActual Revenue$7.79 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AWellgistics Health Announcement DetailsQuarterQ2 2025Date8/19/2025TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Wellgistics Health Earnings HeadlinesPromising Small Cap Stocks To Keep An Eye On - September 16thSeptember 19, 2026 | americanbankingnews.comPromising Pharmaceutical Stocks To Research - September 16thSeptember 19, 2026 | americanbankingnews.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.September 28 at 1:00 AM | Porter & Company (Ad)Best Healthcare Stocks To Follow Today - September 16thSeptember 19, 2026 | americanbankingnews.comDataMeds AI and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National CampaignSeptember 8, 2026 | markets.businessinsider.comDataMeds, Tollo Health Partner NFL Alumni for Rural Health AccessSeptember 8, 2026 | usatoday.comSee More Wellgistics Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Wellgistics Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Wellgistics Health and other key companies, straight to your email. Email Address About Wellgistics HealthWellgistics Health (NASDAQ:MEDS) (NASDAQ:MEDS) is a healthcare technology and pharmaceutical distribution company focused on improving access to prescription medicines. The company provides infrastructure designed to connect healthcare providers, pharmacies, pharmaceutical manufacturers and patients within the prescription-drug supply chain. Its business activities include pharmaceutical distribution and technology-enabled services intended to support medication ordering, fulfillment and delivery. Wellgistics Health has also focused on solutions for digital health and specialty-care providers, including platforms that can help coordinate prescriptions and pharmacy services. The company primarily serves the U.S. healthcare market. Publicly available information about its historical development and executive leadership is limited, and its product offerings and strategic priorities may evolve as the business expands.View Wellgistics Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks3 Stocks Under the Microscope After Large Insider Sales3 Healthcare Stocks Showing Why the Sector Still Has Momentum2 Cybersecurity Stocks Breaking Out as AI Continues to Be a TailwindFertilizer Prices Keep Climbing: 3 Stocks Still Trading at a Discount Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
